BlackRock Fund Advisors’s Integra LifeSciences IART Stock Holding History

BlackRock Fund Advisors’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$208M	Buy	4,855,274 +523,814	+12%	+$21.3M	0.04%	613
2016 Q3	$179M	Buy	4,331,460 +342,824	+9%	+$14.4M	0.04%	612
2016 Q2	$159M	Buy	3,988,636 +283,616	+8%	+$10.2M	0.04%	636
2016 Q1	$125M	Sell	3,705,020 -13,706	-0.4%	-$427K	0.03%	775
2015 Q4	$126M	Buy	3,718,726 +231,258	+7%	+$7.23M	0.03%	785
2015 Q3	$104M	Sell	3,487,468 -301,028	-8%	-$9.41M	0.03%	874
2015 Q2	$104M	Buy	3,788,496 +15,620	+0.4%	+$416K	0.03%	959
2015 Q1	$95.1M	Buy	3,772,876 +172,861	+5%	+$4.09M	0.02%	1040
2014 Q4	$79.8M	Buy	3,600,015 +364,627	+11%	+$7.39M	0.02%	1129
2014 Q3	$65.6M	Buy	3,235,388 +6,874	+0.2%	+$137K	0.02%	1172
2014 Q2	$62.1M	Sell	3,228,514 -31,796	-1%	-$592K	0.02%	1256
2014 Q1	$61.3M	Buy	3,260,310 +62,407	+2%	+$1.2M	0.02%	1255
2013 Q4	$62.4M	Buy	3,197,903 +291,746	+10%	+$5.35M	0.02%	1224
2013 Q3	$47.8M	Buy	2,906,157 +279,561	+11%	+$4.49M	0.02%	1372
2013 Q2	$39.3M	Buy	+2,626,596	New	+$38.5M	0.01%	1403

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Fund Advisors's IART Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Integra LifeSciences (IART) stake by 12% in Q4 2016, buying an estimated $21.3M and bringing the position to 4,855,274 shares worth $208M. The position accounts for 0.04% of the portfolio, ranked #613.

BlackRock Fund Advisors first reported a position in IART in Q2 2013 and has held it in 15 quarters since. 223 funds tracked by Wall St. Rank hold IART as of Q4 2016.

BlackRock Fund Advisors held 4,855,274 shares of Integra LifeSciences worth $208M as of Q4 2016.
BlackRock Fund Advisors bought 523,814 Integra LifeSciences shares in Q4 2016, an estimated $21.3M.
Integra LifeSciences made up 0.04% of BlackRock Fund Advisors's portfolio in Q4 2016, its #613 holding.
BlackRock Fund Advisors first reported a position in Integra LifeSciences in Q2 2013 and has held it in 15 quarters since.
223 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.